CalciMedica (CALC) Current Leases (2022)
CalciMedica's (CALC) quarterly Current Leases came in at $203000.0 in Q4 2022, down 32.78% on a QoQ basis from $302000.0 in Q3 2022.
CalciMedica (CALC) Current Leases (2022) Analysis & Trends
CalciMedica (CALC) has 1 years of Current Leases data on file, last reported at $203000.0 in Q4 2022.
- Quarterly Current Leases changed N/A year-over-year to $203000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $203000.0 (changed N/A YoY) and the FY2022 annual result came in at $203000.0, changed N/A from the prior year.
- Current Leases eased to $203000.0 in Q4 2022, from $302000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $398000.0 in Q2 2022 to a low of $203000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - | - |
| 10 | CalciMedica | 9.98 Mn | -8.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 203,000.00 |
| Sep 30, 2022 | 302,000.00 |
| Jun 30, 2022 | 398,000.00 |
| Mar 31, 2022 | 389,000.00 |